Unsu Jung

Array ( [id] => 8047697 [patent_doc_number] => 20120073577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'COMBINATION PRESSURE THERAPY FOR TREATMENT OF ISCHEMIA AND HEART CONDITIONS, DIABETES, ALZHEIMER\'S DISEASE AND CANCER' [patent_app_type] => utility [patent_app_number] => 13/011058 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13082 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20120073577.pdf [firstpage_image] =>[orig_patent_app_number] => 13011058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12452064 [patent_doc_number] => 09983213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-29 [patent_title] => Identification of subjects being susceptible to anti-angiogenesis therapy [patent_app_type] => utility [patent_app_number] => 13/010183 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10326 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13010183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8606023 [patent_doc_number] => 20130011335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'Materials and Methods Related to Sodium/Potassium Adenosine Triphosphate and SRC' [patent_app_type] => utility [patent_app_number] => 13/521871 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6258 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13521871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959665 [patent_doc_number] => 20110184052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'ARGINASE II: A TARGET FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/975136 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16804 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20110184052.pdf [firstpage_image] =>[orig_patent_app_number] => 12975136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046582 [patent_doc_number] => 20110206648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'Gene-enhanced tissue engineering' [patent_app_type] => utility [patent_app_number] => 12/928805 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18621 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206648.pdf [firstpage_image] =>[orig_patent_app_number] => 12928805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090348 [patent_doc_number] => 20110218144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Method of Reducing Deleterious Effects of Ischemia-Reperfusion' [patent_app_type] => utility [patent_app_number] => 12/971678 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10542 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218144.pdf [firstpage_image] =>[orig_patent_app_number] => 12971678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039493 [patent_doc_number] => 20110092542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'METHODS FOR TREATING SPINAL CORD INJURY WITH A COMPOUND THAT INHIBITS A NCCA-ATP CHANNEL' [patent_app_type] => utility [patent_app_number] => 12/964018 [patent_app_country] => US [patent_app_date] => 2010-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24801 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092542.pdf [firstpage_image] =>[orig_patent_app_number] => 12964018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201697 [patent_doc_number] => 08188248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Nucleic acids encoding interleukin-12P40 variants with improved stability' [patent_app_type] => utility [patent_app_number] => 12/961733 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 31 [patent_no_of_words] => 9920 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188248.pdf [firstpage_image] =>[orig_patent_app_number] => 12961733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8245042 [patent_doc_number] => 08202969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Platelet derived growth factor receptor alpha (PDGFRA) polypeptides comprising activating mutation(s)' [patent_app_type] => utility [patent_app_number] => 12/959588 [patent_app_country] => US [patent_app_date] => 2010-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 28506 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202969.pdf [firstpage_image] =>[orig_patent_app_number] => 12959588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039381 [patent_doc_number] => 20110092430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'METHOD AND COMPOUND FOR THE TREATMENT OF VALVULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 12/956615 [patent_app_country] => US [patent_app_date] => 2010-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10189 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092430.pdf [firstpage_image] =>[orig_patent_app_number] => 12956615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8522232 [patent_doc_number] => 20120321640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'VON WILLEBRAND FACTOR SPECIFIC BINDING AGENTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/512126 [patent_app_country] => US [patent_app_date] => 2010-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17736 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062186 [patent_doc_number] => 20110200605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Polypeptides and use thereof' [patent_app_type] => utility [patent_app_number] => 12/952869 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11123 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200605.pdf [firstpage_image] =>[orig_patent_app_number] => 12952869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8393174 [patent_doc_number] => 20120231006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/510926 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 80276 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8648769 [patent_doc_number] => 20130034499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'SGII AS A PROGNOSTIC MARKER IN CONDITIONS WHICH REQUIRE CRITICAL CARE' [patent_app_type] => utility [patent_app_number] => 13/508798 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17491 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071501 [patent_doc_number] => 20110046352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'DISEASE-RESISTANT PLANTS AND METHOD OF CONSTRUCTING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/938645 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10120 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046352.pdf [firstpage_image] =>[orig_patent_app_number] => 12938645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696222 [patent_doc_number] => 20110230368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'High Throughput Assays for TRPM7' [patent_app_type] => utility [patent_app_number] => 12/916222 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9465 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230368.pdf [firstpage_image] =>[orig_patent_app_number] => 12916222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968622 [patent_doc_number] => 08507433 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-08-13 [patent_title] => 'Cardioprotective effects of GHRH agonists' [patent_app_type] => utility [patent_app_number] => 12/914023 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7608 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12914023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358634 [patent_doc_number] => 20120213798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'METHODS AND USES FOR TREATING HEPATIC ISCHEMIA AND REPERFUSION INJURY' [patent_app_type] => utility [patent_app_number] => 13/504021 [patent_app_country] => US [patent_app_date] => 2010-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12326 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465625 [patent_doc_number] => 20120270793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'METHODS OF TREATING A PATIENT RECEIVING A CARDIAC STENT IMPLANT' [patent_app_type] => utility [patent_app_number] => 13/496408 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12583 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000736 [patent_doc_number] => 20110117113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN DIRECTED AGAINST HUMAN CXCR4 AND OTHER CELL ASSOCIATED PROTEINS AND METHODS TO GENERATE THEM' [patent_app_type] => utility [patent_app_number] => 12/897051 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28527 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117113.pdf [firstpage_image] =>[orig_patent_app_number] => 12897051 [rel_patent_id] =>[rel_patent_doc_number] =>)